Medical Science News

RSS

Can a plant-based diet lower your risk of Parkinson's disease?

A recent study in the journal Movement Disorders examined the association between plant-based diets and Parkinson's disease (PD) risk, using data from 126,283 UK Biobank participants. The research found that those in the highest quartile for healthful plant-based diet indices (hPDI) had a 22% lower risk of PD, while unhealthful plant-based diets (uPDI) correlated with a 38% higher risk.

19 Sep 2023

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

A new research paper was published in Oncotarget's Volume 14 on September 15, 2023, entitled, "Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma."

19 Sep 2023

Rehabilitation for chronic knee pain may not be targeting all the right muscles

A new study from the University of Connecticut has discovered that rehabilitation to address chronic knee pain may not be targeting all the right muscles.

19 Sep 2023

Transforming postpartum depression treatment with neurosteroids

A new study in Neuropsychopharmacology delves into the mechanisms of action of brexanolone, the first FDA-approved, rapid-acting antidepressant specifically for postpartum depression (PPD). The research highlights brexanolone's potential anti-inflammatory effects and its impact on GABAA receptors, offering insights into its efficacy and suggesting avenues for further study.

19 Sep 2023

Two of four sepsis screening tools inadequate for EMS use, study finds

Two out of the four internationally-recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, according to new research presented at the European Emergency Medicine Congress today (Wednesday).

19 Sep 2023

DeepMind develops new tool to predict pathogenicity of missense variants

DeepMind is releasing AlphaMissense, a tool researchers can use to learn more about the effects that missense mutations – which make up the majority of "variants of uncertain significance" – have on disease.

19 Sep 2023

Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer.

19 Sep 2023

Annual NCCN Congress to focus on latest advances in blood cancer treatment

The National Comprehensive Cancer Network 2023 Annual Congress: Hematologic Malignancies returns to San Francisco this week, for the first time since 2019.

19 Sep 2023

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

More than 43 years ago, many Chinese residents were vaccinated with the vaccinia virus Tiantan strain (VTT) to protect them from smallpox infection.

19 Sep 2023

Inactivated poliovirus vaccine elicits persistent immunity for up to 10 years

The neutralizing antibodies persistence of the Sabin strain-derived inactivated poliovirus vaccine.

19 Sep 2023

Study evaluates method of remote screening and assessment for cognitive impairment and dementia

Researchers evaluated the performance of the electronic Clinical Dementia Rating (eCDR) for cognitive impairment and dementia screening among older adults.

19 Sep 2023

Coffee, fiber, and the Mediterranean diet are key players in fighting nonalcoholic fatty liver disease

Dietary patterns, foods, and nutrients to ameliorate nonalcoholic fatty liver disease (NAFLD).

19 Sep 2023

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

Whether a high-dose influenza vaccine is associated with a benefit in reducing CP events.

19 Sep 2023

Early autism diagnosis breakthrough: machine learning uses eye movements on real and artificial faces

An innovative autism spectrum disorder (ASD) detection technique for children by examining eye movement.

19 Sep 2023

First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

Organon today announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), published the results of the RUBY study which reached its primary effectiveness outcome of successfully treating abnormal postpartum uterine bleeding and postpartum hemorrhage with the JADA® System.

19 Sep 2023

Waters launches new walk-up solutions that further simplify the analysis of biologic drug product and cell culture media

Waters Corporation announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis.

From Waters Corporation 19 Sep 2023

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

19 Sep 2023

Stem cell therapy shows promise in treating COVID-19 complications

The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.

19 Sep 2023

Researchers identify new blood marker for dopamine system damage

The marker in question is called DOPA decarboxylase (DCC). In the current study, DCC was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency in the brain. However, the marker was normal in other brain diseases such as Alzheimer's disease. The researchers even noticed that DCC was elevated in individuals with Parkinson's many years before they developed any symptoms.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

Medical Science News

Can a plant-based diet lower your risk of Parkinson's disease?

Real-time live tissue sensitivity assay could be used as a personalized strategy for pancreatic cancer

Rehabilitation for chronic knee pain may not be targeting all the right muscles

Transforming postpartum depression treatment with neurosteroids

Two of four sepsis screening tools inadequate for EMS use, study finds

DeepMind develops new tool to predict pathogenicity of missense variants

Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

Inactivated poliovirus vaccine elicits persistent immunity for up to 10 years

Study evaluates method of remote screening and assessment for cognitive impairment and dementia

Coffee, fiber, and the Mediterranean diet are key players in fighting nonalcoholic fatty liver disease

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

Early autism diagnosis breakthrough: machine learning uses eye movements on real and artificial faces

First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

Waters launches new walk-up solutions that further simplify the analysis of biologic drug product and cell culture media

Ongoing gene therapy trials have driven increased use of ALS genetic testing, finds study

Stem cell therapy shows promise in treating COVID-19 complications

Researchers identify new blood marker for dopamine system damage

Adaptive platform trial shows promise for finding new glioblastoma therapies

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News